From Our Perspective
FDA Holds Workshop to Discuss the Safe Use of Benzodiazepines
By Marta Sokolowska, PhD, Associate Director for Controlled Substances in FDA’s Center for Drug Evaluation and Research
FDA continues to focus on the safe use of benzodiazepines. One critical element of increasing our understanding of their benefits and risks is through collaborations and stakeholder outreach. One of the agency’s initiatives on this important topic was to host a workshop earlier this year with Duke-Margolis Center for Health Policy.
More about Workshop to Discuss the Safe Use of Benzodiazepines
Previous From Our Perspectives